Keyphrases
Improved Diagnosis
100%
CYFRA 21-1
100%
Mesothelioma
100%
Soluble Mesothelin-related Peptides
100%
Benign Disease
50%
Lung Disease
33%
Malignant Mesothelioma
33%
High Concentration
16%
95th Percentile
16%
Serum Levels
16%
Differential Diagnostics
16%
Lung
16%
Cancer Patients
16%
Differential Diagnosis
16%
In Cancer
16%
Malignant Tumor
16%
High Specificity
16%
Cancer Detection
16%
Diagnostic Ability
16%
Healthy Individuals
16%
Ovarian Cancer
16%
Serum Biomarkers
16%
Healthy Donors
16%
Cancer Disease
16%
Cancer Antigen
16%
Squamous Cell Cancer
16%
Neuron-specific Enolase
16%
Carcinoembryonic Antigen
16%
Control Sensitivity
16%
Disease Sensitivity
16%
Lung Cancer Biomarkers
16%
Gastrointestinal
16%
Medicine and Dentistry
Mesothelin
100%
Mesothelioma
100%
Cytokeratin 19 Fragment
100%
Malignant Neoplasm
37%
Benign Tumor
37%
Lung
25%
Pulmonary Disorder
25%
Biological Marker
12%
Cancer Diagnosis
12%
Differential Diagnosis
12%
Tumor Antigen
12%
Ovarian Cancer
12%
Neuron Specific Enolase
12%
Cancer Biomarkers
12%
Squamous Cell
12%
Carcinoembryonic Antigen
12%
Pharmacology, Toxicology and Pharmaceutical Science
Cytokeratin 19 Fragment
100%
Mesothelioma
100%
Mesothelin
100%
Diseases
62%
Malignant Neoplasm
50%
Biological Marker
25%
Normal Human
12%
Lung Cancer
12%
Ovary Cancer
12%
Squamous Cell Carcinoma
12%
Neuron Specific Enolase
12%
Tumor Antigen
12%
Carcinoembryonic Antigen
12%
Biochemistry, Genetics and Molecular Biology
Mesothelin
100%
Blood Level
16%
Normal Human
16%
Carcinoembryonic Antigen
16%
Tumor Antigen
16%
Enolase
16%
Keratin 19
16%